跳至主要内容
临床试验/NCT05690750
NCT05690750招募中不适用

Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.

Institute of Liver and Biliary Sciences, India1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年1月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Prevalence of gastric antral vascular ectasia (GAVE) among cirrhotic patients with diabetes mellitus (fasting blood sugar>126mg/dL, and/or HbA1c >6.5%), compared to cirrhotic patients without diabetes.

研究概览

简要总结

We will evaluate all out-patients and in-patients with cirrhosis, who undergo upper gastrointestinal endoscopy (EGD) in the Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), for inclusion. Patients with cirrhosis, with age >18-years, who have characteristic findings of GAVE on endoscopy will be included in this study. Their clinical and biochemical features, and endoscopy findings will be compared with a gender and age-matched control group of cirrhosis without GAVE. This observational, case-control study will aim to define the predictors of GAVE in patients with cirrhosis.

详细描述

Primary Objective: To study whether GAVE is more prevalent among patients with cirrhosis who have diabetes mellitus, compared to cirrhotic patients without diabetes.

  • Secondary objectives:
  1. Relationship of etiology of cirrhosis with occurrence of GAVE.
  2. Relationship of severity of cirrhosis (CTP score and MELD score), with GAVE.
  3. Features of metabolic syndrome among cirrhotic patients with GAVE.
  4. Variceal grade and previous endotherapy with occurrence of GAVE among patients with cirrhosis.
  5. Prevalence of proximal gastric vascular ectasias among cirrhotic patients with GAVE.

(b) Methodology:

  • Study population:

All out-patients and in-patients who undergo upper gastrointestinal endoscopy (EGD) in the Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), will be evaluated for inclusion. Diagnosis of cirrhosis will be based on a combination of imaging features, liver biopsy, elastography measurements, and signs of portal hypertension.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with cirrhosis, with age >18-years, who have characteristic findings of GAVE on endoscopy.

排除标准

  • Active upper GI bleeding preventing adequate mucosal evaluation.
  • Patients unable or unwilling to give informed consent.
  • Endoscopic treatment of GAVE in past one month.

结局指标

主要结局

Prevalence of gastric antral vascular ectasia (GAVE) among cirrhotic patients with diabetes mellitus (fasting blood sugar>126mg/dL, and/or HbA1c >6.5%), compared to cirrhotic patients without diabetes.

时间窗: 3 months

次要结局

  • Comparison of Model for End-Stage Liver Disease (MELD) scores (on a scale of 6-40) of cirrhotic patients with GAVE and cirrhotic patients without GAVE.(3 months)
  • Prevalence of proximal gastric vascular ectasias among cirrhotic patients with GAVE.(3 months)
  • Comparison of the number of features of metabolic syndrome among cirrhotic patients with GAVE and cirrhotic patients without GAVE.(3 months)
  • Comparison of Child Turcotte Pugh (CTP) scores (on a scale of 5-15) of cirrhotic patients with GAVE and cirrhotic patients without GAVE.(3 months)
  • Grade of esophageal varices among cirrhotic patients with GAVE, compared to cirrhotic patients without GAVE.(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验